Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were down 11.5% during mid-day trading on Saturday . The stock traded as low as C$0.27 and last traded at C$0.27. Approximately 407,425 shares were traded during trading, an increase of 105% from the average daily volume of 198,342 shares. The stock had previously closed at C$0.31.

Voyageur Pharmaceuticals Trading Down 11.5%

The company has a market cap of C$40.91 million, a price-to-earnings ratio of -25.25 and a beta of 0.32. The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84. The firm’s fifty day moving average price is C$0.20 and its 200-day moving average price is C$0.17.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.